Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Development of a novel regenerative bioadhesive for the treatment of infected corneal ulcers.
Author Affiliations & Notes
  • Kuldeep Suhas Dole
    Ophthalmology, PBMA's H. V. Desai Eye Hospital, Pune, Maharashtra, India
    Sight First, Lions Clubs International, Oak Brook, Illinois, United States
  • Yashoda Chandorkar
    Materials meet Life, Empa Standort Sankt Gallen, Sankt Gallen, SG, Switzerland
  • Annina Mittelholzer
    Materials meet Life, Empa Standort Sankt Gallen, Sankt Gallen, SG, Switzerland
  • Kongchang Wei
    Materials meet Life, Empa Standort Sankt Gallen, Sankt Gallen, SG, Switzerland
  • Shilpa Joshi
    Ophthalmology, PBMA's H. V. Desai Eye Hospital, Pune, Maharashtra, India
  • Simon Pot
    Equine Department, Universitat Zurich Vetsuisse-Fakultat, Zurich, Zürich, Switzerland
  • Markus Rottmar
    Materials meet Life, Empa Standort Sankt Gallen, Sankt Gallen, SG, Switzerland
  • Footnotes
    Commercial Relationships   Kuldeep Dole Velux Foundation, Code F (Financial Support); Yashoda Chandorkar Velux Foundation, Code F (Financial Support); Annina Mittelholzer Velux Foundation, Code F (Financial Support); Kongchang Wei Velux Foundation, Code F (Financial Support); Shilpa Joshi Velux Foundation, Code F (Financial Support); Simon Pot Velux Foundation, Code F (Financial Support); Markus Rottmar Velux Foundation, Code F (Financial Support)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 22. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kuldeep Suhas Dole, Yashoda Chandorkar, Annina Mittelholzer, Kongchang Wei, Shilpa Joshi, Simon Pot, Markus Rottmar; Development of a novel regenerative bioadhesive for the treatment of infected corneal ulcers.. Invest. Ophthalmol. Vis. Sci. 2024;65(7):22.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Corneal infections constitute a silent epidemic with >800’000 new cases per year worldwide, often resulting in blindness, which is preventable with timely expert treatment. Surgical treatment options, such as corneal transplantation, are associated with high costs, and require specialist infrastructure and expertise, which are often unavailable in developing countries, leaving such cases untreated. Alternative standard of care procedures for the stabilization of corneal ulcers include cyanoacrylate-based or hydrogel (e.g. fibrin) based glues, which either exhibit a mismatched elastic modulus and exothermic gelation process, or are mechanically weak, rendering them unsuitable for certain types of defects.
To overcome these problems, we have developed an adhesive inspired by dopamine based mussel chemistry which is able to seal a corneal ulcer and serve as drug release system, as well as facilitate cell infiltration from the surrounding microenvironment.

Methods : The adhesive is biodegradable and should support the regeneration of new transparent corneal tissue, and restoration of sight. For this, we mimic crosslinking aspects of catechol chemistry using a two-component glue based on chemically modified cold fish gelatin and hydrogen peroxide (H2O2) as an oxidizing agent to achieve a gelation temperature ≤ 25 °C. To achieve a fast (≤ 2 min) gelation time, as assessed via rheology and tube inversion techniques, that is compatible with the sensitive corneal ulcer environment, we evaluated different H2O2 concentrations.

Results : Mussel inspired chemistry showed the thiourea and the catechol groups that crosslink to form a gel. Crosslinking with the surrounding tissue contributes to the adhesive. NMR data showed modification of cold-fish gelatin with the appearance of another peak at 6.7 ppm.
Tube inversion test showed complete gelation, 2 min after mixing.
In Vitro evaluation using NHDF cell showed that when cells were seeded on the gel surface after gelation, it mimicked a situation where healthy cells from the cornea proliferated and regenerated the injured cornea.
Ex Vivo evaluation in porcine non-infected defect (2 mm diameter) showed that the gelation happed after 3 min and pull out test for adhesion after 20 min showed that gel was firmly adherent to the defect.

Conclusions :
Our results show that the adhesive developed holds promise for corneal application and warrants further in vivo testing.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×